Telemedicine company Hims & Hers Health has been one of the hottest healthcare stocks in recent memory. Changes at ...

Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...

Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new ...

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports ...

The past six months have been a windfall for Hims & Hers Health’s shareholders. The company’s stock price has jumped 90%, ...

Minoxidil — commonly sold under the brand name Rogaine — is the only FDA-approved drug to treat both male and female pattern hair loss. But Shepherd said dosage and application varies due to hormonal ...

Both stocks have huge opportunities still in front of them. When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Healthcare giant Hims & Hers Health Inc (NYSE:HIMS) is one of the best performers on the New York Stock Exchange (NYSE) today, last seen up 9.2% at $36.18, continuing its volatile performance after ...